Immunology

Items 21-30 of 39

per page
Set Descending Direction
  1. anti-Lipoma Preferred Partner, pAb (IG-817)
    AG-25T-0106
    AG-25T-0106-C05050 µg
    CHF 350.00
    Immunocytochemical staining of a rat cardiac fibroblast using anti-Lipoma Preferred Partner, pAb (IG-817) (Prod. No. AG-25T-0106) (LPP; red fluorescence) and a green-fluorescent phalloidin derivative staining filamentous actin. LPP is a protein related to
  2. anti-MDA5 (human), mAb (Hely-1)
    AG-20B-0013
    AG-20B-0013-C100100 µg
    CHF 460.00
  3. anti-NF-κB (p65), pAb
    AG-25T-0004
    AG-25T-0004-R100100 µl
    CHF 290.00
  4. anti-NFATc1, pAb (IG-205)
    AG-25T-0110
    AG-25T-0110-C05050 µg
    CHF 380.00
  5. anti-NFATc2 (human), pAb (IG-209)
    AG-25T-0111
    AG-25T-0111-C02020 µg
    CHF 560.00
  6. anti-PAG [Cbp], pAb (IG-452)
    AG-25T-0108
    AG-25T-0108-C100100 µg
    CHF 450.00
  7. anti-Rab1-GTP, mAb (rec.) (ROF7)
    AG-27B-0006
    AG-27B-0006-C100100 µg
    CHF 390.00
    Rab1-GTP is detected by immunocytochemistry using anti-Rab1-GTP, mAb (ROF7) (Prod. No.  AG-27B-0006). Method: HeLa cells are grown in standard culture conditions, fixed with paraformaldehyde (3%), permeablized in  PBS+ BSA 0.2
  8. anti-RIG-I, mAb (Alme-1)
    AG-20B-0009
    AG-20B-0009-C100100 µg
    CHF 495.00
    Western blot analysis of human RIG-I in HeLa cells by using RIG-I, mAb (Alme-1) (Prod. No. AG-20B-0009).
Method: Cell extracts from HeLa cells either unstimulated (lane 1) or stimulated for 6h (lane 2), 16h (lane 3) or 24 h (lane 4) with Inte
  9. anti-RIG-I, mAb (Alme-1) (Biotin)
    AG-20B-0009B
    AG-20B-0009B-C100100 µg
    CHF 530.00
  10. anti-Survival Motor Neuron Protein (human), mAb (7B10)
    AG-20T-0003
    AG-20T-0003-C200200 µg
    CHF 350.00
    Western Blot using anti-Survival Motor Neuron Protein (human), mAb (7B10) (Prod. No. AG-20T-0003) on 15μg of human platelet lysate as a positive control (15μg). ECL detection.

Items 21-30 of 39

per page
Set Descending Direction
© 2017 Adipogen Life Sciences. Pictures: © 2012 Martin Oeggerli. All Rights Reserved.